Gratus Capital’s Clorox CLX Stock Holding History

Gratus Capital’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,632	Closed	-$243K	–	176
2017 Q4	$243K	Hold	1,632	–	–	0.03%	162
2017 Q3	$215K	Buy	+1,632	New	+$219K	0.03%	172

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

VAM

ValueInvest Asset Management Luxembourg $1.47B AUM 0.87% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Gratus Capital's CLX Position: Q1 2018 in Review

Gratus Capital sold out of Clorox (CLX) in Q1 2018, closing a stake of 1,632 shares — an estimated $243K sold.

Gratus Capital first reported a position in CLX in Q3 2017 and held it in 2 quarters. The position peaked at $243K in Q4 2017. 914 funds tracked by Wall St. Rank hold CLX as of Q1 2018.

Gratus Capital reported no remaining Clorox position as of Q1 2018 after selling out during the quarter.
Gratus Capital sold 1,632 Clorox shares in Q1 2018, an estimated $243K.
Gratus Capital first reported a position in Clorox in Q3 2017 and held it in 2 quarters.
Gratus Capital's Clorox position peaked at $243K in Q4 2017.
914 funds tracked by Wall St. Rank held Clorox as of Q1 2018.

Based on Gratus Capital's 13F filing for Q1 2018, filed 10 May 2018.